[go: up one dir, main page]

AU2003264544A1 - Method of evaluationg canceration degree of mammal-origin specimen - Google Patents

Method of evaluationg canceration degree of mammal-origin specimen

Info

Publication number
AU2003264544A1
AU2003264544A1 AU2003264544A AU2003264544A AU2003264544A1 AU 2003264544 A1 AU2003264544 A1 AU 2003264544A1 AU 2003264544 A AU2003264544 A AU 2003264544A AU 2003264544 A AU2003264544 A AU 2003264544A AU 2003264544 A1 AU2003264544 A1 AU 2003264544A1
Authority
AU
Australia
Prior art keywords
evaluationg
mammal
canceration degree
specimen
origin specimen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003264544A
Other versions
AU2003264544A8 (en
Inventor
Atsushi Kaneda
Toshikazu Ushijima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
National Cancer Center Japan
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of AU2003264544A8 publication Critical patent/AU2003264544A8/en
Publication of AU2003264544A1 publication Critical patent/AU2003264544A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
AU2003264544A 2002-09-26 2003-09-22 Method of evaluationg canceration degree of mammal-origin specimen Abandoned AU2003264544A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-280683 2002-09-26
JP2002280683 2002-09-26
PCT/JP2003/012055 WO2004029291A1 (en) 2002-09-26 2003-09-22 Method of evaluationg canceration degree of mammal-origin specimen

Publications (2)

Publication Number Publication Date
AU2003264544A8 AU2003264544A8 (en) 2004-04-19
AU2003264544A1 true AU2003264544A1 (en) 2004-04-19

Family

ID=32040492

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003264544A Abandoned AU2003264544A1 (en) 2002-09-26 2003-09-22 Method of evaluationg canceration degree of mammal-origin specimen

Country Status (2)

Country Link
AU (1) AU2003264544A1 (en)
WO (1) WO2004029291A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002078516A2 (en) * 2001-03-30 2002-10-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of cancer
JP2003235573A (en) * 2002-02-13 2003-08-26 Sumitomo Pharmaceut Co Ltd Diabetic nephropathy marker and its use

Also Published As

Publication number Publication date
WO2004029291A1 (en) 2004-04-08
AU2003264544A8 (en) 2004-04-19

Similar Documents

Publication Publication Date Title
AU2003217737A1 (en) Method of analyzing investments using overlapping periods
AU2003211625A1 (en) Method of modifying protein properties
AU2003220407A1 (en) Method of preparing polyestercarbonates
AU2003900810A0 (en) Method of scheduling
AU2003282558A1 (en) Nanopellets and method of making nanopellets
AU2003293027A1 (en) Probe array and method of its manufacture
AU2003277596A1 (en) Method of deuterization
AU2003215185A1 (en) Method of making window unit
AU2003269126A1 (en) Method of combining materials
AU2003249323A1 (en) Method of polycarbonate preparation
AU2003217086A1 (en) Method of pipette calibration
AUPS096002A0 (en) Method of construction
AU2003211752A1 (en) Method of manufacturing pipe
AU2003276825A1 (en) Method of immunotherapy
AU2002951913A0 (en) Method of treatment
AU2003264544A1 (en) Method of evaluationg canceration degree of mammal-origin specimen
AU2003234235A1 (en) Method of fingerprinting tissue samples
AU2003219628A1 (en) Method of preserving biological materials
AU2003235231A1 (en) Method of synthesizing cf3-chf-cf2-nr2
AU2002323945A1 (en) Method of evaluating degree of canceration of mammal-origin specimen
AU2003226871A1 (en) Pearl culture method
AU2003290512A1 (en) Method of weldbonding
AU2003222584A1 (en) Method of producing organoacyloxysilanes
AU2003257587A1 (en) Method of evaluating degree of canceration of human-origin specimen
AU2003299623A1 (en) Method of making mercaptoalkylalkyldialkoxysilanes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase